ALAMEDA, Calif.--(BUSINESS WIRE)--InSite Vision Incorporated (AMEX:ISV - News) announced today that it has signed a licensing and distribution agreement with Bioceutica S.A., an ophthalmology-focused Argentine pharmaceutical company, for InSite’s AzaSite® (azithromycin ophthalmic solution) 1% for the treatment of bacterial conjunctivitis (pink eye).
